z-logo
Premium
Small Molecule Allosteric Modulation of Protein Tyrosine Kinases in Live Cells
Author(s) -
Lasansky David,
Bienick Matthew,
Ghosh Indraneel
Publication year - 2018
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2018.32.1_supplement.798.2
Subject(s) - allosteric regulation , kinase , microbiology and biotechnology , protein tyrosine phosphatase , receptor tyrosine kinase , proto oncogene tyrosine protein kinase src , tyrosine kinase , biochemistry , phosphatase , biology , protein kinase a , signal transduction , cell signaling , chemistry , phosphorylation , enzyme
The protein kinase and phosphatase enzymes within a cell catalyze the addition or removal of a phosphate group onto a protein respectively, and previous research has shown their involvement in nearly all cell‐signaling pathways. A consequence of this is that the disruption of the function of a particular kinase or phosphatase may lead to the development of diseases such as cancer. A major goal of chemical biology is to develop methods that allow for a detailed understanding of cell‐signaling pathways. However, current methods for studying the roles of these enzymes in signaling such as CRISPR‐Cas9 and siRNA for gene knockout suffer from potential compensatory mechanisms in the cell. Our research has led to the development of a potentially general approach for controlling enzyme activity via insertion of small peptide chains (BH3 helices) which bind selectively to a protein partner (Bcl‐xL) (Figure 1) for allosteric inhibition of kinase activity. Kinase activity can then be modulated by the addition of a specific small molecule that disrupts BH3/Bcl‐xL interactions thus providing specific control over turning on a single type of protein kinase within a cell. This approach is distinct compared to an approach by Professor Shokat that allows turning off activity of individual protein kinases in cells. We have shown success with this model in live cells when applied to the tyrosine‐protein kinase c‐Src, and our current project focuses on applying the model to other homologous tyrosine‐protein kinases. If successful, this research will provide greater insight into the role of specific kinases in cell‐signaling pathways, and thus allow for the development of genetic and small molecule therapeutics targeted towards dysfunctional kinases. Support or Funding Information This work was supported by the National Institutes of Health [1R01GM115595‐01] and the National Science Foundation [CHE‐1506091]. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom